您的购物车当前为空
Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC).
别名 ZD 6474, Zactima, Vandetanib, HSDB 8198, Caprelsa
Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC).

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 11,700 | 1-2周 | |
| 50 mg | ¥ 15,300 | 1-2周 | |
| 100 mg | ¥ 19,500 | 1-2周 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Vandetanib Fumarate is an orally available tyrosine kinase inhibitor. Vandetanib Fumarate works by blocking RET (REarranged during Transfection), vascular endothelial growth factor receptor (VEGFR-2, VEGFR-3), and epidermal growth factor receptor and to a lesser extent VEGFR-1, which are important targets in thyroid cancer (TC). |
| 别名 | ZD 6474, Zactima, Vandetanib, HSDB 8198, Caprelsa |
| 分子量 | 591.43 |
| 分子式 | C26H28BrFN4O6 |
| CAS No. | 338992-00-0 |
| Smiles | COC1=C(C=C2N=CN=C(C2=C1)NC3=C(C=C(C=C3)Br)F)OCC4CCN(CC4)C.O=C(/C=C/C(O)=O)O |
| 密度 | 1.406 g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多